The HypoPal brand, founded in 2015 (Denmark), from 5 sister brands and 2214 competing brands. The HypoPal brand is owned by Zealand Pharma, a company listed in XCSE. The International Securities Identification Number (ISIN) of Zealand Pharma is DK0060257814. HypoPal belongs to the Biotechnology business sector.

HypoPal is a brand of Zealand Pharma (ZEAL/C) Share price

International deposit : 2015 Business sector Biotechnology

Share price and profitability of the share Zealand Pharma (HypoPal)

Buy Zealand Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested DKK 599.00

Portfolio valuation
Zealand Pharma (HypoPal) over 5 years* DKK 2,939.79

Stock market history Zealand Pharma (HypoPal)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Zealand Pharma

Zealand Pharma
Zealand Pharma
See more brands of Zealand Pharma

Rival brands
HypoPal

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS